Weill Medical College Of Cornell University
Clinical trials sponsored by Weill Medical College Of Cornell University, explained in plain language.
-
New CLL strategy: add immune therapy only when needed
Disease control OngoingThis study tests a personalized approach for people with CLL, a type of blood cancer. Instead of giving everyone three drugs from the start, patients first receive two oral medications (zanubrutinib and venetoclax). Only those who still have signs of cancer after that get an addi…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 28, 2026 13:02 UTC
-
New radiation therapy shows promise for tough prostate cancer
Disease control OngoingThis study tests a drug called 225Ac-J591, which delivers radiation directly to prostate cancer cells. It is for men with advanced prostate cancer that has stopped responding to hormone therapy. The first part finds a safe dose, and the second part checks if the drug can lower PS…
Phase: PHASE1, PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 26, 2026 20:03 UTC
-
Could a 2-Week radiation course be as safe as 4 weeks for recurrent prostate cancer?
Disease control OngoingThis study compares two radiation schedules for prostate cancer that has returned after prostate removal. One group gets 20 treatments over 4 weeks, the other gets 5 treatments over 2 weeks. The main goal is to see if the shorter course causes similar or fewer bowel and urinary s…
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated Apr 26, 2026 20:00 UTC
-
Could ditching Beta-Blockers boost energy in heart disease patients?
Symptom relief ENROLLING_BY_INVITATIONThis study looks at whether older adults (65+) with a specific type of heart disease called TTR cardiac amyloidosis feel better when they stop taking a common heart medication called a beta-blocker. Twenty participants will go through two periods—one on the drug and one off—to co…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Apr 26, 2026 20:01 UTC
-
New app aims to combat loneliness in older HIV survivors
Symptom relief OngoingThis study tests a tablet-based app called COPPEhR designed to help older adults (50+) living with HIV for at least 15 years feel less lonely and depressed. The app provides social connection, resources, and memory support. Researchers will compare the app group to a group that o…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Symptom relief
Last updated Apr 26, 2026 20:01 UTC
-
New drug shows promise in bladder cancer window trial
Knowledge-focused OngoingThis study tests a drug called abemaciclib in 20 people with bladder cancer who cannot receive standard chemotherapy. Participants take the drug for a short time before their bladder removal surgery. Researchers compare tumor samples taken before and after treatment to see how th…
Phase: EARLY_PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Apr 28, 2026 13:02 UTC
-
Caffeine and nail fungus drug: a risky mix?
Knowledge-focused ENROLLING_BY_INVITATIONThis study looks at whether drinking caffeine changes blood pressure or heart rate in people taking the nail fungus medication terbinafine. Researchers will measure these changes in 52 adults who are starting terbinafine. The goal is to understand if caffeine and terbinafine inte…
Phase: NA • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:02 UTC
-
Can a custom trial help heart patients decide on their meds?
Knowledge-focused ENROLLING_BY_INVITATIONThis study tests a personalized approach called N-of-1 to help older adults with a type of heart failure decide whether to keep taking beta-blockers. Participants will try different medication schedules and report their confidence and preferences. The goal is to see if this metho…
Phase: PHASE4 • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:02 UTC
-
Scientists test new way to see inside brain tumors
Knowledge-focused TerminatedThis study tests a new imaging method to look at oxygen levels and cell growth in high-grade brain tumors. About 8 adults with suspected high-grade glioma will get special PET scans before treatment. The goal is to understand why some tumors resist standard therapy, which may hel…
Phase: PHASE1 • Sponsor: Weill Medical College of Cornell University • Aim: Knowledge-focused
Last updated Apr 26, 2026 20:00 UTC